Standards for new drug examination data more to define.

Published: 2002-02-04 07:00:00
Updated: 2002-02-04 07:00:00
The KFDA plans to refine the scope of the examination data more precisely for drug or new drug reviews, and to reinforce the administrative punishment.

The current provisions required the drug efficacy data for drugs or new drug reviews by diseases or patients, the drug adverse reaction data ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.